← Leaderboards
Jordan Blair Strom
Beth Israel Deaconess Medical Center
$3,484,739
Attributed
$3,484,739
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,484,739 · 3
By mechanism
R01$2,398,742 · 1
K23$1,036,763 · 1
F32$49,234 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Francesca N Delling$5,534,111
- Robert Yeh$7,955,025
- Elliot Chaikof$40,570,541
- Aristidis Veves$14,937,543
- Robert R. Edelman$10,829,918
Others in their field
Other Emerging Leaders on “Risk Factors”
- Chanza Baytop · Westat, Inc.$271,217,917
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Scott Hensley · University Of Pennsylvania$48,258,374
- Susan M Landau · University Of California Berkeley$47,252,026
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
- Dale Sandler · Social And Scientific Systems, Inc.$41,380,317
Research focus
Risk FactorsPhenotypeInsightLinkCardiovascular SystemAortic Valve ReplacementBiologicalBiological MarkersProspectiveFundingMedicalEtiologyOperative Surgical ProceduresStrokeAortic Valve StenosisAdultCardiovascular DiseasesEnrollmentAdverse OutcomeIsraelImpairmentAdverse Event RiskHigh RiskAdverse Event
Grant awards (10)
Chronic Renal Insufficiency and Silent Progression of Aortic Stenosis (CRISP-AS)$763,572
R01 · FY2025 · HL · contact PI
Chronic Renal Insufficiency and Silent Progression of Aortic Stenosis (CRISP-AS)$763,809
R01 · FY2024 · HL · contact PI
Chronic Renal Insufficiency and Silent Progression of Aortic Stenosis (CRISP-AS)$871,361
R01 · FY2023 · HL · contact PI
Identification of the Components of Frailty Using Administrative Data and Metabolite Profiling$172,800
K23 · FY2023 · HL · contact PI
Frailty, Aging, and Risk of Adverse Outcomes in Mitral Valve Prolapse (FAR-OUT-MVP Study)$172,763
K23 · FY2023 · HL · contact PI
Identification of the Components of Frailty Using Administrative Data and Metabolite Profiling$172,800
K23 · FY2022 · HL · contact PI
Identification of the Components of Frailty Using Administrative Data and Metabolite Profiling$172,800
K23 · FY2021 · HL · contact PI
Identification of the Components of Frailty Using Administrative Data and Metabolite Profiling$172,800
K23 · FY2020 · HL · contact PI
Identification of the Components of Frailty Using Administrative Data and Metabolite Profiling$172,800
K23 · FY2019 · HL · contact PI
LINKING CLINICAL TRIAL AND REGISTRY DATA TO EVALUATE RISKS AND BENEFITS OF AORTIC VALVE REPLACEMENT (AVR) STRATEGIES$49,234
F32 · FY2018 · HL · contact PI